Aveanna Healthcare Holdings Inc. (AVAH)
NASDAQ: AVAH · Real-Time Price · USD
3.735
-0.235 (-5.92%)
At close: Aug 1, 2025, 4:00 PM
3.810
+0.075 (2.01%)
After-hours: Aug 1, 2025, 7:29 PM EDT
Intra-Cellular Therapies Market Cap
AVAH has a market cap or net worth of $771.48 million as of August 1, 2025. Its market cap has increased by 4.16% in one year.
Market Cap
771.48M
Enterprise Value
2.19B
1-Year Change
4.16%
Ranking
Category
Stock Price
$3.74
Market Cap Chart
Since the IPO on April 29, 2021, AVAH's market cap has decreased from $2.16B to $771.48M, a decrease of -64.32%. That is a compound annual growth rate of -21.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 771.48M | -12.63% |
| Dec 31, 2024 | 883.04M | 72.75% |
| Dec 29, 2023 | 511.16M | 252.49% |
| Dec 30, 2022 | 145.02M | -89.36% |
| Dec 31, 2021 | 1.36B | -36.96% |
| Apr 29, 2021 | 2.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.14B |
| Johnson & Johnson | 404.67B |
| AbbVie | 339.52B |
| Novo Nordisk | 238.11B |
| UnitedHealth Group | 237.18B |
| AstraZeneca | 230.79B |
| Novartis AG | 227.32B |
| Abbott Laboratories | 223.99B |